---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle announced the publication of a study validating performance of the i31-SLNB algorithm to determine sentinel lymph node biopsy positivity risk."
publishedDateTime: 2021-11-06T01:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
webUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "jwzUFrHv/CbB3i8ODxwUwZ/nyrG8sYnprPIV3FNhEPfVnhwgtjpQk7+LpXLQj3sGGX986lfjHg7ksd/mI9EIxxK6/TRhhvN1eztmwSvNxvNxZt9VqtG+cZ1MD8NOkarJoB+BUiU3r5JTFR36Uu9q99IZXXVxWifKjZBZFBLvmMLkxDCoG0YrTdXz5kDSCMsA6uy574SNbfW7uCozxrtDhieydHSubMCoQRKooQp4Aj0ifhnD+bhsltXrVae+Ga0DSIG7nsIEXVPfQ5rzur2/l4V/Tzb+nd45VP7fdpAi/WaHhT7Fedvp+0O36CNCEWCJ8Wsfwo19BK+jy7VO1B5btNcJlfPg5JVwjw77/nxRcgU=;/9qnNCOLeGOs+JpAI6CGhg=="
---

